Australian Pharmaceutical Patents Expiring March 2014 - Phillips Ormonde Fitzpatrick

Below is a report from IP Organisers (an independent service company of Phillips Ormonde Fitzpatrick) detailing Australian Pharmaceutical Patents (that have been granted extensions) and that are due to expire in the coming month.

This report covers Australian patents whose Extension of Term expires in March 2014.

Australian Pharmaceutical Patents

Expiring March 2014

www.iporganisers.com/pharma/march2014.htm

Active Ingredient	Tirofiban hydrochloride
Trade Name	Affrastat
Chemical Name	N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-L-tyrosine monohydrochloride monohydrate
Chemical Structure
Australian Patent	AU-B-655436
Expiry Date	16 March 2014
Patent Assignee	Correvio LLC
Title	Novel sulfonamide fibrinogen receptor antagonists
Abstract	A series of non-peptide derivatives of generic formula I that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
Australian Register of Therapeutic Goods	ARTG ID 65161 ARTG ID 65162
Consumer Medicine Information	Aggrastat (Tirofiban hydrochloride)
Product Information	Aggrastat (Tirofiban hydrochloride)

For further information please contact Rodney Chiang-Cruise or Aaron McMillan at IP Organisers Pty Ltd